Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
China Life Insurance A | Shanghai | Financial | Insurance | CN¥1.17T | 13.4x | 0.09 | CN¥41.43 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.9% Downside | Upgrade to Pro+ | |
Ping An Insurance | Shanghai | Financial | Insurance | CN¥951.74B | 7.9x | 0.77 | CN¥52.62 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.2% Upside | Upgrade to Pro+ | |
People's Insurance | Shanghai | Financial | Insurance | CN¥292.63B | 4.6x | 0.1 | CN¥7.32 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.5% Downside | Upgrade to Pro+ | |
China Pacific Insurance | Shanghai | Financial | Insurance | CN¥216.42B | 5.1x | 0.17 | CN¥33 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.3% Upside | Upgrade to Pro+ | |
New China Life Insurance | Shanghai | Financial | Insurance | CN¥68.57B | 3.5x | 14.57 | CN¥49.64 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.7% Downside | Upgrade to Pro+ | |
COFCO Capital Holdings | Shenzhen | Financial | Insurance | CN¥32.72B | 24.2x | 2.3 | CN¥14.20 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hubei Biocause Pharmaceutical | Shenzhen | Financial | Insurance | CN¥23.37B | -30.7x | 0.1 | CN¥4.73 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jiangxi Tianli Technology INC | Shenzhen | Financial | Insurance | CN¥6.12B | 170.1x | 0.42 | CN¥30.95 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |